In conclusion, these findings highlight the critical role of both methylation and acetylation in the initiation, progression and outcome of maladaptive cardiac remodelling and dysfunction and HDAC inhibitors are promising drugs to target cardiac hypertrophic signalling for heart failure treatment. This evidence concerns the gene HDAC9 and heart failure.